Management of Joint Pain During Pregnancy
For joint pain during pregnancy, use short-acting NSAIDs like ibuprofen at the lowest effective dose for 7-10 days maximum during the first and second trimesters only, stopping completely by gestational week 28, with prednisone/prednisolone ≤5 mg/day as an alternative if needed. 1
First-Line Approach: NSAIDs (First and Second Trimester Only)
Ibuprofen is the preferred NSAID due to the most reassuring safety data, followed by diclofenac 1. The key principles are:
- Use only short-acting, nonselective NSAIDs (avoid COX-2 inhibitors due to limited data) 1, 2
- Lowest effective dose for shortest duration (7-10 days maximum) 1
- Mandatory discontinuation after gestational week 28 to prevent fetal complications including oligohydramnios and premature ductus arteriosus closure 1, 2
- Early pregnancy NSAID exposure shows no increased risk of miscarriage or birth defects 1
Critical Caveat for Conception
If the patient is having difficulty conceiving, discontinue NSAIDs entirely as periovulatory exposure can induce luteinized unruptured follicle syndrome, reducing fertility 1, 2.
Second-Line: Low-Dose Glucocorticoids
When NSAIDs are insufficient or contraindicated:
- Prednisone or prednisolone ≤5 mg/day is associated with low risk and can be used throughout pregnancy 1
- These agents are not associated with increased major birth defects 1
- Avoid doses >5 mg/day when possible due to dose-related risks: pregnancy-associated osteoporosis, gestational diabetes, serious infections, and preterm birth 1
- If higher doses are needed (up to 10-20 mg/day), strongly consider adding pregnancy-compatible steroid-sparing agents 2
Third Trimester Pain Management
After gestational week 28, NSAIDs are absolutely contraindicated 1, 2. Options include:
- Low-dose prednisone/prednisolone (≤5 mg/day) as the safest choice 1
- Acetaminophen/paracetamol (though evidence requires careful consideration per 3)
- Non-pharmacologic measures become increasingly important
For Inflammatory Arthritis Specifically
If joint pain is due to underlying rheumatic disease requiring disease-modifying therapy:
- Hydroxychloroquine, sulfasalazine (≤2 g/day with folic acid), azathioprine, and colchicine (1-2 mg/day) are compatible throughout pregnancy 1, 2
- Certolizumab (TNF inhibitor) has minimal placental transfer and can be continued throughout pregnancy 2
- Other TNF inhibitors (infliximab, adalimumab, etanercept, golimumab) may be continued but have significant third-trimester placental transfer 1, 2
Absolute Contraindications
Methotrexate, mycophenolate, and cyclophosphamide are teratogenic and must be discontinued 1-3 months before conception 1, 2.
Algorithm Summary
- Weeks 0-28: Ibuprofen (lowest dose, ≤7-10 days) OR prednisone ≤5 mg/day
- Week 28 onward: STOP all NSAIDs; use prednisone ≤5 mg/day if needed
- If trying to conceive: Avoid NSAIDs entirely
- If inflammatory arthritis: Add pregnancy-compatible DMARDs as above
The evidence strongly supports this tiered approach, with the 2025 EULAR guidelines 1 providing the most current and comprehensive framework, reinforced by 2020 ACR recommendations 2.